No. As of September 2026, Molina Healthcare, Inc. (MOH) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 36.2% / 30% · (Cash+Inv) / Mkt Cap (36m) 85.6% / 30% · Interest income / Revenue 0.00% / 5% | Fail |
| S&P Global | Debt / Mkt Cap (36m) 36.2% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 82.3% / 33% · Receivables / Mkt Cap (36m) 32.2% / 49% · Interest income / Revenue 0.00% / 5% | Fail |
| Dow Jones | Debt / Mkt Cap (24m) 36.2% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 82.3% / 33.33% · Receivables / Mkt Cap (24m) 32.2% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| MSCI | Debt / Avg Assets (4Q) 23.7% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 55.0% / 33.33% · Receivables / Avg Assets (4Q) 21.7% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
| FTSE | Debt / Total Assets 24.1% / 33.33% · (Cash+ST Inv) / Total Assets 54.8% / 33.33% · (Cash+Recv) / Total Assets 76.3% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
No. As of September 2026, Molina Healthcare, Inc. (MOH) is classified as NOT HALAL by Maz Vantage: it fails every published Shariah screening standard it could be measured against (AAOIFI, S&P Global, Dow Jones, MSCI and FTSE).
No. Molina Healthcare, Inc. is over the AAOIFI limit on Debt / Mkt Cap (36m) and (Cash+Inv) / Mkt Cap (36m).
Molina Healthcare, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.
Molina Healthcare, Inc. (NYSE: MOH) is a Healthcare company (Medical - Healthcare Plans) with a market capitalization of $11.5B. The Maz Rating grades it against the other companies in its sector.
Molina Healthcare, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $221.21, Molina Healthcare, Inc. trades at 0.3x sales and 2.8x book value, with an EV/EBITDA of 33.2. Over the last twelve months it generated about $43.4B of revenue and a net loss of $32M. It runs a gross margin of 8.1%, an operating margin of 0.4% and a net margin of -0.1%. It shows return on equity of -1.2%, return on invested capital of 2.1% and a free cash flow yield of 2.1%. On the balance sheet: a debt-to-equity ratio of 0.95 and a current ratio of 1.69. Over the past 52 weeks the share price ranged from $121.06 to $244.89, with a beta of 0.74.
Molina Healthcare, Inc. does not currently pay a dividend.
39 Wall Street analyst ratings cover the stock: 17 Buy, 16 Hold and 6 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Molina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom qualified for Medicaid, Medicare, or other government-sponsored healthcare plans. Established in 1980, the company maintains its corporate headquarters in Long Beach, California.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.